A Review of Sitagliptin With Special Emphasis on Its Use in Moderate to Severe Renal Impairment

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s32331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Linagliptin Added to Sulphonylurea in Uncontrolled Type 2 Diabetes Patients With Moderate-To-Severe Renal Impairment

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Managing Diabetic Patients With Moderate or Severe Renal Impairment Using DPP-4 Inhibitors: Focus on Vildagliptin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2013English

Murepavadin, a Novel Antipseudomonal Antibiotic: Pharmacokinetics, Tolerability and Safety in Subjects With Mild, Moderate, and Severe Renal Function Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Living With Moderate to Severe Renal Failure From the Perspective of Patients

BMC Nephrology
Nephrology
2016English

Safety and Efficacy of Ibrutinib in a Patient With Severe Renal Impairment

Hematology Reports
Hematology
2017English

Pms46 Impact of Etanercept on Work and Activity Impairment in Employed Patients With Moderate to Severe Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

A Review on Labeo Calbasu (Hamilton) With an Emphasis on Its Conservation

Journal of Fisheries
2015English

Pharmacokinetics of Flupirtine in Elderly Volunteers and in Patients With Moderate Renal Impairment.

Postgraduate Medical Journal
Medicine
1988English

Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy